Optic neuropathy and recurrence of papilledema in patients with craniosynostosis may be a clinically useful biomarker by PHOMS.

People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye condition ...

Patients who underwent bilateral treatment experienced a higher rate of clinically relevant recovery, the authors reported.

Meeting the minimum requirement for vitamin B12, needed to make DNA, red blood cells and nerve tissue, may not actually be ...

In this Healio Video Perspective from Telling It Like It Is, Andrew G. Lee, MD, explains why a team approach is needed for neuro-ophthalmic conditions.

The Congress on Controversies in Ophthalmology will be held April 4-5 in Seville, Spain.As the name implies, the unique characteristic of this meeting is that it is fully devoted to ongoing debates in ...

While there are a lot of uncertainties about the links between these medications and blindness, this is “worthy of investigation,” says Howard Krauss, M.D., a surgical neuro-ophthalmologist and ...

A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking semaglutide and tirzepatide, popular drugs for type 2 diabetes and obesity. In ...

Neuro-ophthalmologic sequelae are common in ... 1 Departments of Neurology & Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, 3400 Spruce Street, 3 W Gates Building ...

Chandigarh: The three-day National Conference of Neuro-Ophthalmology 2025 (NCNO-2025) commenced at PGI on Friday. Day one of the conference was packed with workshops, training sessions ...

That prompted Katz to post a question on a national neuro-ophthalmology listserv to see if his colleagues were seeing similar things in their patients. Neuro-ophthalmology merges the fields of ...